Low, S;
Mohamed, R;
Davidson, A;
Papadopoulos, M;
Grassi, P;
Webster, AR;
Black, GC;
... Bloom, PA; + view all
(2020)
A new paradigm for delivering personalised care: integrating genetics with surgical interventions in BEST1 mutations.
Eye
, 34
pp. 577-583.
10.1038/s41433-019-0553-5.
Preview |
Text
Garway-Heath Eye Final- MANUSCRIPT FINALMAY 2019.pdf - Accepted Version Download (397kB) | Preview |
Preview |
Text
Garway-Heath Figure 1.pdf - Accepted Version Download (183kB) | Preview |
Preview |
Text
Garway-Heath Figure 2.pdf - Accepted Version Download (186kB) | Preview |
Preview |
Text
Garway-Heath Figure 3-FINAL.pdf - Accepted Version Download (420kB) | Preview |
Abstract
BACKGROUND: The availability and reduced cost of genotyping has improved gene susceptibility testing and our scientific understanding of disease pathophysiology. Whilst several personalised translational models exist within medical frameworks, genetic-based surgical therapy is a translational application not widely used in surgical specialties. METHOD: We present a clinical series of five patients with genetically confirmed bestrophinopathy and malignant glaucoma (MG). Patients were followed up for 12 months or more after receiving surgical intervention to manage refractory intraocular pressure (IOP) resistant to medical treatment. FINDINGS: Patients with BEST1 gene mutations are at higher risk of MG after filtration surgery. A multi-disciplinary approach after four patients experienced poor outcomes concluded that traditional first-line glaucoma surgery was not sufficient to prevent visual loss. A fifth patient presenting with the identified at-risk phenotype underwent primary pars plana vitrectomy, with pars plana Baerveldt tube insertion, successfully preventing MG and had no glaucoma progression after 5 years. INTERPRETATION: We provide proof-of-principle that genetic analysis can be used to inform the selection of surgical therapy to improve outcomes. In this case, a refinement of current surgical methods to avoid MG. Although challenges remain, personalised surgery has the potential to improve clinical outcomes beyond the scope of current surgical practice.
| Type: | Article |
|---|---|
| Title: | A new paradigm for delivering personalised care: integrating genetics with surgical interventions in BEST1 mutations |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1038/s41433-019-0553-5 |
| Publisher version: | https://doi.org/10.1038/s41433-019-0553-5 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Hereditary eye disease, Quality of life |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
| URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10082215 |
Archive Staff Only
 |
View Item |
